maderis gail j  the wall street transcript gail j maderis gail j maderis is president of genzyme molecular oncology with more than  years of management experience in biotechnology and healthcare environments ms maderis possesses a diverse portfolio of knowledge and skills in business management research and development and gene therapy in  ms maderis conceived and created genzyme molecular oncology one of genzyme corporation’s three tracking stock divisions which focuses on the development and commercialization of innovative therapeutics to treat cancer during the process of creating the division ms maderis managed genzyme’s acquisition of pharmagenics inc and initiated the major partnerships that became the cornerstone of the business under her leadership genzyme molecular oncology has signed more than a dozen commercial agreements with pharmaceutical companies for use of its proprietary sage differential gene expression technology the division also has formed business partnerships with worldclass companies such as purdue pharma and the pharmaceutical division of kirin brewery japan additionally it collaborates with several prominent academic and research organizations including the national cancer institute the johns hopkins university danafarber cancer institute and massachusetts general hospital prior to forming genzyme molecular oncology ms maderis was vice president and business manager of genzyme corporation’s cystic fibrosis and gene therapy programs prior to joining genzyme ms maderis spent seven years as a manager at bain  company inc where she was responsible for developing and implementing major strategic programs for several large companies in the pharmaceutical and healthcare industries she earned a bachelor’s degree with honors in business administration from the university of california berkeley in  and received an mba from harvard business school in  related interviewsgail maderis  genzyme molecular oncology gzmonovember  gail maderis  genzyme molecular oncologyoctober  gail maderis  genzyme molecular oncology gzmomay   cartlatest newsall american usc footbal player joseph m boskovich jr now picks all american value stocks for his clientspaul hogan picks tech dividend growers microchip technology nasdaqmchp xilinx nasdaqxlnx and versum materials nysevsm gallons of water to produce a mcdonalds nysemcd quarter pounder how will investors profitthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsprotecting assets through a rulesbased fundpaula r wieck published july   in investing strategiesbuy managing risk through strict quality standardsjeffrey p cornellmichael s jordan published july   in investing strategiescompanies covered aapl goog sap nsrgy buy identifying emergingmarket and international stocks with a bottomup processrahul sharma published july   in investing strategiescompanies covered  ge asx tsm hdfc lukoy xom tot rdsa ibulhsgfin arclk buy most popular reportsinvesting strategies published july  buy wireless communications  telecom published july  buy investing strategies published july  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsprotecting assets through a rulesbased fundmanaging risk through strict quality standardsidentifying emergingmarket and international stocks with a bottomup process analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript  terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google gail j maderis  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors gail j maderis check out list of companies and businesses related to gail j maderis find out gail j maderis address and contact details view other people related to gail j maderis  coworkers colleagues companions etc address  lombard st san francisco  ca companies related to gail j maderis cikcompany namepositioncompany addressopexa therapeutics incdirector  technology forest blvd the woodlands novabay pharmaceuticals incdirector  powell street suite  emeryville  gail j maderis on the web persons related to gail j maderis  opexa therapeutics incnamepositioncityjeffrey adducitomballalbert  margaret alkek foundationhoustongregory baileydirector the woodlandsgregory baileydirector londontimothy c barabedirector woburntimothy c barabedirector the woodlandsbrooks boverouxthe woodlandsmcwilliams davidthe woodlandsjorden davidthe woodlandsjorden davidthe woodlandsjorden davidthe woodlandshung davidthe woodlandsdwayne deslattetomballrill donnathe woodlandsrill donnathe woodlandspaul frisonhoustonpaul frisondirector the woodlandspaul frisondirector the woodlandsr wayne fritzschelutzmaderis gailthe woodlandsmaderis gailthe woodlandsrobert h gowtomballhanspeter hartungdirector the woodlandsdon healeychief scientific officer the woodlandslynne hohlfeldcfo the woodlandsdavid hungdirector the woodlandsdavid hungdirector san franciscodavid hungdirector the woodlandsgeorge jarkesy owner tomballthompson jayethe woodlandsthompson jayethe woodlandsdavid emerson jordendirector the woodlandsdavid emerson jordendirector the woodlandsdavid emerson jordendirector the woodlandstony kaminhoustontony kamindirector the woodlandstony kamindirector the woodlandswarren c lautomballwarren c lau tomballalec n litowitzevanstongail j maderisdirector san franciscogail j maderisdirector the woodlandsmagnetar capital partners llcevanstonmagnetar capital partners lpevanstonmagnetar financial llc owner evanstonmarxe austin w  greenhouse david m owner new yorkdavid mcwilliamstomballdavid mcwilliamshoustondavid mcwilliamsdirector the woodlandsrichman michaelthe woodlandsrichman michaelthe woodlandsrichman michaelthe woodlandswarma neilthe woodlandswarma neilthe woodlandswarma neilthe woodlandsjason g ottesonceo and cfo huntsvillekarthik radhakrishnanchief financial officer the woodlandslorin randalldirector hawthornelorin randallthe woodlandsmichael richmandirector germantownmichael richmandirector houstonmichael richmandirector the woodlandsmichael richmandirector the woodlandsmichael richmandirector the woodlandsdonna r rillchief development officer the woodlandsdonna r rillchief development officer the woodlandsbrian rodriguezhoustonbrian rodriguezthe woodlandsmichael roth owner st francismichael rothst franciswilliam rousetomballwilliam rousecfo the woodlandswilliam rousecfo the woodlandsseaman scottthe woodlandsseaman scottthe woodlandsseaman scottthe woodlandsscott b seamandirector springscott b seamanhoustonscott b seamandirector houstonscott b seamandirector houstonscott b seamandirector the woodlandscharles e sheedyhoustonpeter paul smetek jrhoustonbrian jay starkst francisbrian jay starkst francissupernova management llcevanstonjaye thompsonsr vp clin dev  reg affairs the woodlandsjaye thompsonsvp clinical dev  reg affairs the woodlandsneil k warmapresident ceo and acting cfo the woodlandsneil k warmapresident  ceo the woodlandsneil k warmapresident  ceo the woodlandsneil k warmapresident  ceo the woodlandsterry wesnerthe woodlandsterry wesnerdirector the woodlandsjimmy calvin williamschief operating officer the woodlandspersons related to gail j maderis  novabay pharmaceuticals incnamepositioncitymark brian andersoncso emeryvillemark brian andersonemeryvillekeith r bleysvp product development emeryvillecharles cashiondirector emeryvillecashion charlesemeryvillechina pioneer pharma holdings ltd owner grand caymanchina pioneer pharma holdings ltd owner grand cayman cayman islandsanthony dailleydirector emeryvilleanthony dailleydirector emeryvilleanthony dailleydirector emeryvillepaul e freimandirector emeryvillepaul e freimandirector emeryvillepaul e freimandirector emeryvillejian ping fu owner burwood australiamaderis gailemeryvillejustin hallsvp general counsel emeryvilleharry f hixson jrdirector emeryvillerussell a hoonsenior vice president emeryvillehall justinemeryvillebehzad khosrovisvp product development emeryvillebehzad khosrovivp research and development emeryvillebehzad khosrovisvp product development  cao emeryvillexinzhou lidirector shanghai pr of chinaxinzhou li owner shanghai pr of chinaxinzhou li owner shanghaixiaoyan liudirector emeryvilleyonghao madirector emeryvillegail j maderisdirector san franciscogail j maderisdirector emeryvillesieczkarek markemeryvilleradaelli massimoemeryvillet alex mcphersondirector emeryvillet alex mcphersondirector emeryvillebob wu mijiaemeryvillewu mijiaemeryvillenajafi family trust dated september  emeryvilleramin najafichief executive officer emeryvilleramin najafichief executive officer emeryvilleramin najaficheif executive officer emeryvilleramin najafichief executive officer emeryvillenaqu area pioneer pharma co ltd owner shanghai pr of chinajohn james oreillychief financial officer emeryvillejohn james oreillysvp business and corporate dev emeryvillejohn james oreillyemeryvillefreiman paulemeryvillethomas j paulsoncfo thomas j paulsoncfo emeryvillethomas j paulsonchief financial officer emeryvillethomas j paulsoncfo emeryvillethomas j paulsoncfo emeryvillepioneer pharma hong kong co ltd owner kowloonpioneer pharma hong kong co ltd owner lai chi kok kowloon hkpioneer pharma singapore pte ltd owner singaporepioneer pharma singapore pte ltd owner singaporemassimo radaellidirector cambridgemassimo radaellidirector emeryvilleron najafi raminemeryvillewu royemeryvillecolin scottvp clinical research and deve emeryvillemark m sieczkarekceo san carlosmark m sieczkarekdirector emeryvilledavid w stromansvp ophthalmic product devt emeryvillealex mcpherson temeryvillemcpherson temeryvillepaulson thomasemeryvillezavodnick toddemeryvillewicks tonyemeryvillerobert r tuftsdirector emeryvilletony ds wicksdirector emeryvilletony ds wicksdirector emeryvilletony ds wicksdirector emeryvillemijia wudirector emeryvilleroy j wusvp bus  corp development roy j wusvp bus  corp development emeryvilleroy j wuemeryvillehenry liu xiaoyanemeryvilleliu xiaoyanemeryvillepaul li xinzhouemeryvilletodd erik zavodnickdirector pleasanton gail j maderis mba executive profile  biography  bloomberg july    am et biotechnology company overview of antiva biosciences inc snapshotpeople  overviewboard memberscommittees executive profile gail j maderis mbachief executive officer and president antiva biosciences incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background ms gail j maderis mba serves as the chief executive officer and president at antiva biosciences inc ms maderis served as the chief executive officer and president of bay area bioscience association formerly baybio she served as the chief executive officer and president of five prime therapeutics inc from  to june   prior to joining fiveprime in july  she spent eleven years at genzyme corporation in various business development and general  management positions while at genzyme she founded and served as president of genzyme molecular oncology now genzyme oncology inc and was appointed as a corporate vice president of genzyme corporation she practiced management and strategy consulting with bain  co inc she served as a director of bay area bioscience association since april  and novabay pharmaceuticals inc since october  ms maderis has been an independent director of opexa therapeutics inc since october   she served as a director of five prime therapeutics inc she serves on the mayors biotech advisory council of san francisco harvard business school california research center and hbs healthcare initiative ms maderis received a bs degree in business from the university of california at berkeley and an mba from harvard business schoolread full background corporate headquarters menlo park california united statesphone fax  board members memberships presentdirectornovabay pharmaceuticals incpresentindependent directoropexa therapeutics inc education mba harvard business schoolbs university of california berkeley other affiliations genzyme oncology incharvard business schoolfive prime therapeutics incuniversity of california berkeleybay area bioscience associationopexa therapeutics incnovabay pharmaceuticals inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact antiva biosciences inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close opexa therapeutics  opexa elects gail maderis to board of directors homeabout opexa about opexamanagement teamboard of directorsscientific advisory boardfacilitycontact us tcelna® tcelna® descriptionterms phase b overviewms overviewpublications opx opx descriptionneuromyelitis optica clinical trials abilit clinical study for secondary progressive multiple sclerosis overviewimmform® clinical management tool technology tcell platformopexa cgmp manufacturingpipeline news  resources multimediapress releaseswebcastspublicationsconference  meeting presentations investor relations why investpress releasesevents  presentationsstock informationsec filingsfinancial reportscorporate governanceanalyst coverageinvestor faqs careers working at opexaopen positionshow to applyliving in the woodlandscontact us contact us homenews  resourcespress releasespress releases details news  resources multimedia press releases webcasts publications conference  meeting presentations multimediapress releaseswebcastspublicationsconference  meeting presentations quick links financial reports faqs contact ir about opexa tcelna® clinical trials contact us email alerts email address  mailing lists  releases sec filings presentation events   enter the code shown above  unsubscribe from email alerts opexa elects gail maderis to board of directors  download this press release  industry expert brings significant expertise to tovaxin® clinical development program the woodlands tx november   – opexa therapeutics inc nasdaq opxa today announced the election of gail j maderis to its board of directors at its annual meeting of shareholders held on october   ms maderis will chair the board’s nominating and corporate governance committee as well as serve on the board’s compensation committee we are very pleased to welcome gail to the board as she brings a wealth of experience in the healthcare industry as a former senior executive in genzyme and past ceo of five prime therapeutics commented neil k warma president and chief executive officer of opexa gail’s successful leadership in these companies including her accomplishments in corporate partnerships and clinical development will greatly enhance our capabilities at the board level along with her industry knowledge gail has acquired an extensive network of contacts related to financing partnering and support services for the industry in her current position as ceo of baybio and her advisory role to the national ms society gail’s appointment to the board greatly benefits opexa and its shareholders as we position tovaxin toward its next clinical trial stage of development opexa is developing an innovative therapy for the treatment of multiple sclerosis that i believe has the potential to bring significant benefits to patients commented gail maderis opexa’s patientspecific therapy brings the power of personalized medicine to ms and has the potential to treat both relapsingremitting and secondary progressive disease the company has positioned itself well as it prepares for its next clinical trial with tovaxin and i am looking forward to supporting the senior team and board in their endeavors and representing the interests of shareholders gail j maderis bio ms maderis is president and ceo of baybio bay area bioscience association an independent nonprofit trade association serving the life sciences industry in northern california she was previously president and ceo of fiveprime therapeutics inc a biotechnology company focused on the discovery and development of innovative protein and antibody drugs prior to this ms maderis held senior management positions at genzyme corporation including founder and president of genzyme molecular oncology a publicly traded division of genzyme and corporate vice president of genzyme corporation she also is a director of novabay pharmaceuticals inc and serves on the mayors biotech advisory council of san francisco as well as the hbs healthcare initiative board along with comprehensive experience in corporate development ms maderis brings to the board of directors extensive involvement in strategic management a successful track record of working with investors and partners to finance clinical development deep insight into regulatory and business policy trends impacting the biopharma industry and a demonstrated understanding of governance issues facing emerging companies ms maderis received a bs degree in business from the university of california at berkeley and an mba from harvard business school about opexa opexa therapeutics inc is dedicated to the development of patientspecific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis ms the company’s leading therapy tovaxin® is a personalized cellular immunotherapy treatment that is in late stage clinical development for ms tovaxin is derived from tcells isolated from peripheral blood expanded ex vivo and reintroduced into the patients via subcutaneous injections this process triggers a potent immune respons against specific subsets of autoreactive tcells known to attack myelin and thereby reduces the risk of relapse over time for more information visit the opexa therapeutics website at wwwopexatherapeuticscom cautionary statement relating to forward  looking information for the purpose of safe harbor provisions of the private securities litigation reform act of  this press release contains forwardlooking statements which are made pursuant to the safe harbor provisions of section a of the securities act of  as amended and section e of the securities exchange act of  as amended the words expects believes anticipates estimates may could intends exploring evaluating and similar expressions are intended to identify forwardlooking statements the forwardlooking statements in this release do not constitute guarantees of future performance investors are cautioned that statements in this press release which are not strictly historical statements including without limitation statements regarding the development of the companys product candidate tovaxin constitute forwardlooking statements such forwardlooking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated including without limitation risks associated with our capital position the ability of the company to enter into and benefit from a partnering arrangement for the companys product candidate tovaxin on reasonably satisfactory terms if at all our dependence if partnered on the resources and abilities of any partner for the further development of tovaxin our ability to compete with larger better financed pharmaceutical and biotechnology companies new approaches to the treatment of our targeted diseases our expectation of incurring continued losses our uncertainty of developing a marketable product our ability to raise additional capital to continue our treatment development programs and to undertake and complete any further clinical studies for tovaxin the success of our clinical trials the efficacy of tovaxin for any particular indication such as for rrms or spms our ability to develop and commercialize products our ability to obtain required regulatory approvals our compliance with all food and drug administration regulations our ability to obtain maintain and protect intellectual property rights including for tovaxin the risk of litigation regarding our intellectual property rights the success of third party development and commercialization efforts with respect to products covered by intellectual property rights transferred by the company our limited manufacturing capabilities our dependence on thirdparty manufacturers our ability to hire and retain skilled personnel our volatile stock price and other risks detailed in our filings with the securities and exchange commission these forwardlooking statements speak only as of the date made we assume no obligation or undertaking to update any forwardlooking statements to reflect any changes in expectations with regard thereto or any change in events conditions or circumstances on which any such statement is based you should however review additional disclosures we make in our reports filed with the securities and exchange commission including our annual report on form  k for the year ended december     opexa therapeutics inc all rights reserved privacy policy terms of use powered by q inc  gail maderis antiva biosciences inc profile  biography  bloomberg feedback gail maderis presidentceo antiva biosciences inc career history presidentceo antiva biosciences inc present founder genzyme molecular oncology present advisor natl ms society present presidentceo baybio  presidentceo five prime therapeutics inc  presidentfounder genzyme molecular oncology  corporate vp genzyme corp  vice president genzyme corp  directorcorporate development genzyme corp  founder genzyme molecular oncology former show more corporate information address  rue saint raphael marina ca united states phone  fax  from the web personal information education university of california berkeley bachelors degree business harvard business school mba memberships board memberships opexa therapeutics inc board member present novabay pharmaceuticals inc board member present baybio board member  five prime therapeutics inc board member unknown show more other memberships hbs healthcare initiative board board member the mayors biotech advisory council od san francisco member sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data gail j maderis  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in gail j maderis former board member at novabay pharmaceuticals inc view full profile are you gail j maderis claim your profile   sign up for equilar atlas and view gail j maderiss full profile with equilar atlas you can identify corporate executives in gail j maderiss network and community follow changes in gail j maderiss employment and moneyinmotion connect with gail j maderis through your network of contacts gail j maderiss executive work history past to view gail j maderiss complete executive work history sign up now age      gail j maderiss biography gail maderis mba has served as a director of novabay since october  ms maderis is currently the president chief executive officer and a board member of antiva biosciences inc antiva a privately held biopharmaceutical company focused on developing topical therapeutics for hpvbased diseases previously ms maderis served as the president and chief executive officer of baybio an independent nonprofit trade association serving the life sciences industry in northern california from  until its merger with the california healthcare institute in early  from  to  ms maderis was president and chief executive o  read more gail maderis mba has served as a director of novabay since october  ms maderis is currently the president chief executive officer and a board member of antiva biosciences inc antiva a privately held biopharmaceutical company focused on developing topical therapeutics for hpvbased diseases previously ms maderis served as the president and chief executive officer of baybio an independent nonprofit trade association serving the life sciences industry in northern california from  until its merger with the california healthcare institute in early  from  to  ms maderis was president and chief executive officer of fiveprime therapeutics inc a biotechnology company focused on the discovery and development of innovative protein and antibody drugs and prior to that she held general management positions at genzyme corporation including founder and president of genzyme molecular oncology a publicly traded division of genzyme corporation and corporate vice president of genzyme corporation from  to  ms maderis has been a member of several private company boards of directors and currently serves on the board of opexa therapeutics inc nasdaqcm opxa ms maderis received a bs degree in business administration from the university of california at berkeley and an mba from harvard business school the board considers ms maderis current experience at antiva and prior experiences as chief executive officer of fiveprime therapeutics inc and as president of genzyme molecular oncology to be an asset to the board as it gives her operational and industry experience and leadership skills through her experience she has acquired an extensive network of contacts related to financing partnering and support services for the industry which are important to our board in addition the board believes ms maderis experience as chief executive officer of baybio to be an asset to the board because it resulted in ms maderis having insight into business and policy trends that impact the biopharma industry source novabay pharmaceuticals inc on    sign up for equilar atlas and view gail j maderiss full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like gail j maderis more specifically youll be able to identify corporate executives in gail j maderiss network and community follow changes in gail j maderiss employment and moneyinmotion connect with gail j maderis through your network of conections view full profile   search for over  executive profiles bio example gail j maderis popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla david j oconnor president and ceo the madison square garden company carl g annessa evp and coo hornbeck offshore services inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   opexa therapeutics  opexa elects gail maderis to board of directors homeabout opexa about opexamanagement teamboard of directorsscientific advisory boardfacilitycontact us tcelna® tcelna® descriptionterms phase b overviewms overviewpublications opx opx descriptionneuromyelitis optica clinical trials abilit clinical study for secondary progressive multiple sclerosis overviewimmform® clinical management tool technology tcell platformopexa cgmp manufacturingpipeline news  resources multimediapress releaseswebcastspublicationsconference  meeting presentations investor relations why investpress releasesevents  presentationsstock informationsec filingsfinancial reportscorporate governanceanalyst coverageinvestor faqs careers working at opexaopen positionshow to applyliving in the woodlandscontact us contact us precision immunotherapy™ homeinvestor relationspress releasespress release details investor relations why invest press releases events  presentations stock information sec filings financial reports corporate governance analyst coverage investor faqs why investpress releasesevents  presentationsstock informationsec filingsfinancial reportscorporate governanceanalyst coverageinvestor faqs quick links financial reports faqs contact ir email alerts email address  mailing lists  releases sec filings presentation events   enter the code shown above  unsubscribe from email alerts opexa elects gail maderis to board of directors  download this press release  industry expert brings significant expertise to tovaxin® clinical development program the woodlands tx november   – opexa therapeutics inc nasdaq opxa today announced the election of gail j maderis to its board of directors at its annual meeting of shareholders held on october   ms maderis will chair the board’s nominating and corporate governance committee as well as serve on the board’s compensation committee we are very pleased to welcome gail to the board as she brings a wealth of experience in the healthcare industry as a former senior executive in genzyme and past ceo of five prime therapeutics commented neil k warma president and chief executive officer of opexa gail’s successful leadership in these companies including her accomplishments in corporate partnerships and clinical development will greatly enhance our capabilities at the board level along with her industry knowledge gail has acquired an extensive network of contacts related to financing partnering and support services for the industry in her current position as ceo of baybio and her advisory role to the national ms society gail’s appointment to the board greatly benefits opexa and its shareholders as we position tovaxin toward its next clinical trial stage of development opexa is developing an innovative therapy for the treatment of multiple sclerosis that i believe has the potential to bring significant benefits to patients commented gail maderis opexa’s patientspecific therapy brings the power of personalized medicine to ms and has the potential to treat both relapsingremitting and secondary progressive disease the company has positioned itself well as it prepares for its next clinical trial with tovaxin and i am looking forward to supporting the senior team and board in their endeavors and representing the interests of shareholders gail j maderis bio ms maderis is president and ceo of baybio bay area bioscience association an independent nonprofit trade association serving the life sciences industry in northern california she was previously president and ceo of fiveprime therapeutics inc a biotechnology company focused on the discovery and development of innovative protein and antibody drugs prior to this ms maderis held senior management positions at genzyme corporation including founder and president of genzyme molecular oncology a publicly traded division of genzyme and corporate vice president of genzyme corporation she also is a director of novabay pharmaceuticals inc and serves on the mayors biotech advisory council of san francisco as well as the hbs healthcare initiative board along with comprehensive experience in corporate development ms maderis brings to the board of directors extensive involvement in strategic management a successful track record of working with investors and partners to finance clinical development deep insight into regulatory and business policy trends impacting the biopharma industry and a demonstrated understanding of governance issues facing emerging companies ms maderis received a bs degree in business from the university of california at berkeley and an mba from harvard business school about opexa opexa therapeutics inc is dedicated to the development of patientspecific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis ms the company’s leading therapy tovaxin® is a personalized cellular immunotherapy treatment that is in late stage clinical development for ms tovaxin is derived from tcells isolated from peripheral blood expanded ex vivo and reintroduced into the patients via subcutaneous injections this process triggers a potent immune respons against specific subsets of autoreactive tcells known to attack myelin and thereby reduces the risk of relapse over time for more information visit the opexa therapeutics website at wwwopexatherapeuticscom cautionary statement relating to forward  looking information for the purpose of safe harbor provisions of the private securities litigation reform act of  this press release contains forwardlooking statements which are made pursuant to the safe harbor provisions of section a of the securities act of  as amended and section e of the securities exchange act of  as amended the words expects believes anticipates estimates may could intends exploring evaluating and similar expressions are intended to identify forwardlooking statements the forwardlooking statements in this release do not constitute guarantees of future performance investors are cautioned that statements in this press release which are not strictly historical statements including without limitation statements regarding the development of the companys product candidate tovaxin constitute forwardlooking statements such forwardlooking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated including without limitation risks associated with our capital position the ability of the company to enter into and benefit from a partnering arrangement for the companys product candidate tovaxin on reasonably satisfactory terms if at all our dependence if partnered on the resources and abilities of any partner for the further development of tovaxin our ability to compete with larger better financed pharmaceutical and biotechnology companies new approaches to the treatment of our targeted diseases our expectation of incurring continued losses our uncertainty of developing a marketable product our ability to raise additional capital to continue our treatment development programs and to undertake and complete any further clinical studies for tovaxin the success of our clinical trials the efficacy of tovaxin for any particular indication such as for rrms or spms our ability to develop and commercialize products our ability to obtain required regulatory approvals our compliance with all food and drug administration regulations our ability to obtain maintain and protect intellectual property rights including for tovaxin the risk of litigation regarding our intellectual property rights the success of third party development and commercialization efforts with respect to products covered by intellectual property rights transferred by the company our limited manufacturing capabilities our dependence on thirdparty manufacturers our ability to hire and retain skilled personnel our volatile stock price and other risks detailed in our filings with the securities and exchange commission these forwardlooking statements speak only as of the date made we assume no obligation or undertaking to update any forwardlooking statements to reflect any changes in expectations with regard thereto or any change in events conditions or circumstances on which any such statement is based you should however review additional disclosures we make in our reports filed with the securities and exchange commission including our annual report on form  k for the year ended december     opexa therapeutics inc all rights reserved privacy policy terms of use powered by q inc  opxaw gail j maderis insider trades for opexa therapeutics inc wt bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close opexa therapeutics inc wt nasdaq opxaw go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus opexa therapeutics inc wt after hours  quotes are delayed by  min jul    pm opxaw quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual gail j maderis ms gail j maderis is president  chief executive officer at antiva biosciences inc independent director at opexa therapeutics inc and independent director at novabay pharmaceuticals inc she is on the board of directors at opexa therapeutics inc novabay pharmaceuticals inc and trinity biosystems inc ms maderis was previously employed as president  chief executive officer by the bay area bioscience association president by genzyme molecular oncology president  chief executive officer by five prime therapeutics inc a principal by bain  co inc and vice president by genzyme corp she received her undergraduate degree from the university of california berkeley and an mba from harvard business school transactions date shares transaction value     award at  per share      award at  per share      award at  per share      award at  per share      award at  per share      award at  per share      derivativenonderivative trans at  per share      award at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr neil k warma president chief executive officer cfo  director dr hanspeter hartung independent director mr timothy c barabe independent director ms gail j maderis independent director mr michael s richman independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aamds stock soars toward month high as analysts boost price targets after upbeat results acities to move to if you want to work in tech — not including san francisco abiogen shares surge  after goldman sachs upgrade abiogen upgraded to buy at goldman sachs on alzheimers drug underleveraged balance sheet athe allure of ‘damaged’ stocks as tech mania goes wild aall the signs silicon valley isn’t nearly as awesome as it thinks it is aupdate six flags shares dip  premarket after company misses profit revenue estimates apenske automotive raises quarterly dividend to  cents from  cents apenske automotive raises quarterly dividend to  cents vs  cents aus steel shares jump  premarket after earnings beat jp morgan rates stock overweight a‘stealth’ trump factors are lifting stocks these strategists say aearnings preview nestle under activist pressure aglaxo sharpens rd drops  research programs aearnings preview roche test results pose concerns aboeings stock jumps after profit beat and raised outlook offset sales miss aamazon to host first job fair on august  with  us jobs to fill aford shares fall  premarket acemexs profit buoyed by lower costs aexxon earnings will stock trade higher on expected secondquarter beat achevron earnings wall street is looking for updates on naturalgas projects loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  opxa gail j maderis insider trades for opexa therapeutics inc bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close opexa therapeutics inc nasdaq opxa go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus opexa therapeutics inc market closed  quotes are delayed by  min jul    pm opxa quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual gail j maderis ms gail j maderis is president  chief executive officer at antiva biosciences inc independent director at opexa therapeutics inc and independent director at novabay pharmaceuticals inc she is on the board of directors at opexa therapeutics inc novabay pharmaceuticals inc and trinity biosystems inc ms maderis was previously employed as president  chief executive officer by the bay area bioscience association president by genzyme molecular oncology president  chief executive officer by five prime therapeutics inc a principal by bain  co inc and vice president by genzyme corp she received her undergraduate degree from the university of california berkeley and an mba from harvard business school transactions date shares transaction value     award at  per share      award at  per share      award at  per share      award at  per share      award at  per share      award at  per share      derivativenonderivative trans at  per share      award at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr neil k warma president chief executive officer cfo  director dr hanspeter hartung independent director mr timothy c barabe independent director ms gail j maderis independent director mr michael s richman independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aamds stock soars toward month high as analysts boost price targets after upbeat results acities to move to if you want to work in tech — not including san francisco abiogen shares surge  after goldman sachs upgrade abiogen upgraded to buy at goldman sachs on alzheimers drug underleveraged balance sheet athe allure of ‘damaged’ stocks as tech mania goes wild aall the signs silicon valley isn’t nearly as awesome as it thinks it is aupdate six flags shares dip  premarket after company misses profit revenue estimates apenske automotive raises quarterly dividend to  cents from  cents apenske automotive raises quarterly dividend to  cents vs  cents aus steel shares jump  premarket after earnings beat jp morgan rates stock overweight a‘stealth’ trump factors are lifting stocks these strategists say aearnings preview nestle under activist pressure aglaxo sharpens rd drops  research programs aearnings preview roche test results pose concerns aboeings stock jumps after profit beat and raised outlook offset sales miss aamazon to host first job fair on august  with  us jobs to fill aford shares fall  premarket acemexs profit buoyed by lower costs aexxon earnings will stock trade higher on expected secondquarter beat achevron earnings wall street is looking for updates on naturalgas projects loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  peoplelookercom updating data on  live please help us narrow down your search all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming im not sure please enter a full name please help us narrow down your search first name please enter first name last name please enter last name people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates robot check enter the characters you see below sorry we just need to make sure youre not a robot for best results please make sure your browser is accepting cookies type the characters you see in this image try different image continue shopping conditions of use privacy policy   amazoncom inc or its affiliates amazoncom amazon music unlimited interesting finds updated daily amazon try prime digital music all departments alexa skills amazon devices amazon video amazon warehouse deals appliances apps  games arts crafts  sewing automotive parts  accessories baby beauty  personal care books cds  vinyl cell phones  accessories clothing shoes  jewelry    women    men    girls    boys    baby collectibles  fine art computers courses credit and payment cards digital music electronics gift cards grocery  gourmet food handmade health household  baby care home  business services home  kitchen industrial  scientific kindle store luggage  travel gear luxury beauty magazine subscriptions movies  tv musical instruments office products patio lawn  garden pet supplies prime exclusive prime pantry software sports  outdoors tools  home improvement toys  games vehicles video games wine go departments en   hello sign inaccount  listssign inaccount  listsorderstry primecart your amazoncomtodays dealsgift cards  registrysellhelpdisability customer support amazon music unlimited prime music cds  vinyl download store open web player mp cart settings mo for prime members nonprime price month change or cancel anytime start your day free trial mo for prime members nonprime price month change or cancel anytime start your day free trial mo for prime members nonprime price month change or cancel anytime start your day free trial any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening any song anywhere tens of millions of songs with new releases from todays most popular artists listen adfree with unlimited skips download for offline listening already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  already using prime music upgrade to amazon music unlimited now to unlock tens of millions of songs including the hottest new releases only month or year  months for the price of  better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more better with echo  just ask play your favorite music with innovative alexa voice controls exclusive to amazon music want amazon music unlimited just on your echo learn more choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial choose the right amazon music plan for you learn more learn more learn more questions see our faq start free trial theres a problem loading this menu right now learn more about amazon prime get fast free shipping with amazon prime prime members enjoy free twoday shipping and exclusive access to music movies tv shows original audio series and kindle books  get started v